Neurology Devices Market Outlook in United Kingdom to 2017 - Neurostimulation Devices, Interventional Neurology and Other
- Published: March 2011
The United Kingdom Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)’s 5 and 10-year forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.
BMI’s United Kingdom Pharmaceuticals & Healthcare Report provides industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the British pharmaceutical and healthcare industry.
Key Benefits
- Benchmark BMI’s independent 5 and 10-year pharmaceutical and healthcare industry forecasts on United Kingdom to test other views – a key input for successful budgeting and strategic business planning in the British pharmaceutical and healthcare market.
- Target business opportunities and risks in the British pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in United Kingdom.
- Assess the activities, strategy and market position of your competitors, partners and clients
READ MORE >
SWOT Analysis
UK Pharmaceuticals And Healthcare Industry SWOT
UK Political SWOT
UK Economic SWOT
Pharmaceutical Business Environment Ratings
Table: Western Europe Pharmaceuticals Business Environment Ratings For Q211
Risks
UK – Market Summary
Regulatory Regime
Regulatory Developments
Innovative Medicines
Generic Medicines
OTC Medicines
Intellectual Property Issues
Counterfeit Pharmaceuticals
Table: Examples Of Recalls Of Counterfeit Medicines In The UK
Pricing Regime
Table: Bilateral Comparisons For Ex-Manufacturer Prices*
Generic Drug Prices
OTC Prices
Reimbursement Regime
Industry Developments
Epidemiology
Non-Communicable Disease
Communicable Diseases
Healthcare Sector
Healthcare Financing
Health Insurance
Health Tourism
Wholesale Sector
Wholesale Sector Developments
Retail Sector
UK Registered Retail Pharmacies As Of March 2008
Parallel Imports
Research & Development
Biotechnology
Clinical Trials
Industry Forecast Scenario
Overall Market Forecast
Table: Pharmaceutical Sales Indicators 2007-2015
Key Growth Factors – Industry
Table: Healthcare Expenditure Indicators 2007-2015
Table: Government Healthcare Expenditure Indicators 2007-2015
Table: Private Healthcare Expenditure Indicators 2007-2015
Key Growth Factors – Macroeconomic
Table: United Kingdom – Economic Activity, 2007-2015
Prescription Drug Market Forecast
Table: Prescription Drug Sales Indicators 2007-2015
Patented Drug Market Forecast
Table: Patented Drug Market Indicators 2007-2015
Generic Drug Market Forecast
Table: Generic Drug Sales Indicators 2007-2015
OTC Medicine Market Forecast
Table: OTC Medicine Sales Indicators 2007-2015
Pharmaceutical Trade Forecast
Table: Exports and Imports Indicators 2007-2015
Medical Device Market Forecast
Key Risks to BMI Forecasts
Competitive Landscape
Pharmaceutical Industry
Top 20 UK-Based Pharmaceutical Companies According To Market Capitalisation
Top 20 UK-Based Biotechnology Companies According To Market Capitalisation
Company Developments
Table: Leading Pharmaceutical Corporations In The UK By Market Share (2007)
Table: Top Pharmaceutical Products In The UK (2007)
Table: Cost Of Prescriptions* Dispensed In Various Disease Areas, 1995-2006 (GBPmn)
Company Profiles
Leading Indigenous Manufacturers
GlaxoSmithKline
AstraZeneca
Leading Multinational Manufacturers
Pfizer
Novartis
Sanofi-Aventis
Merck & Co
Country Snapshot: UK Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education and Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market and Spending Power
Table: Employment Indicators, 2000-2005
Table: Consumer Expenditure, 2000-2011 (US$)
Table: Average Annual Wages, 2000-2012
BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
- GlaxoSmithKline
- AstraZeneca
- Pfizer
- Novartis
- Sanofi-Aventis
- Merck & Co
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |